Sigma share price drops after shareholders vote on Chemist Warehouse merger

The results are in.

| More on:
A company manager presents the ASX company earnings report to shareholders at an AGM.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sigma Healthcare Ltd (ASX: SIG) share price is falling after the company released the results of last night's shareholder vote on the proposed merger with Chemist Warehouse.

The Sigma share price is 2.64% lower at $2.95 at the time of writing.

The ASX 200 healthcare stock opened at $3.10 per share, up 2.3% on yesterday's closing price.

But it reversed course quickly and tumbled into the red within the first 15 minutes of trading.

Let's check out the details of the vote.

Sigma share price down despite merger approval

Sigma shareholders voted overwhelmingly in favour of the proposed merger with CW Group Holdings Limited at last night's meeting in Melbourne.

In a statement released to the market last night, Sigma said the merger received 99.86% approval from shareholders.

Four Chemist Warehouse executives were elected to the Sigma Healthcare board.

Chemist Warehouse co-founder and board chair Jack Gance received 91.92% support to become a non-executive director.

Chemist Warehouse's CEO Mario Verrocchi, Chief Property Officer Damien Gance, and Chief People Officer Danielle Di Pilla each received more than 97% support to become executive directors.

In an address before the Sigma shareholders' vote, Sigma chair Michael Sammells said the merger would accelerate Sigma's strategic direction "by bringing together two complementary businesses with complementary core strengths and expertise to enhance our service offering to customers".

He said:

Sigma has world-class distribution infrastructure and capability that is delivering best in class service
to pharmacies across Australia every day.

Chemist Warehouse has unparalleled pharmacy franchise and marketing know-how and expertise which will also help elevate our support for our Amcal and Discount Drug Store franchisees.

Given the nature and value accretion of the proposed transaction, Sigma Directors unanimously recommend that Shareholders vote in favour of the Resolutions.

Sammells said the merger would create a wide range of growth opportunities in Australia and overseas.

Following the Sigma shareholders' vote, a scheme meeting and vote were conducted among Chemist Warehouse shareholders.

The merger received 99.23% support at that meeting.

What's next?

The scheme is now subject to court approval next Monday, 3 February, in Melbourne.

If approved, Chemist Warehouse will lodge the orders of the court with the Australian Securities and Investments Commission (ASIC) the following day.

This will make the scheme legally effective and binding on Chemist Warehouse shareholders.

The indicative date for implementation of the transaction is 12 February.

New Sigma shares issued under the scheme are expected to commence trading on a normal settlement basis on 13 February.

Broker downgrades Sigma shares

According to The Australian, Ord Minnett has cut its rating on Sigma shares to a hold.

Should you invest $1,000 in Sigma Healthcare right now?

Before you buy Sigma Healthcare shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma Healthcare wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Bored man sitting at his desk with his laptop.
Healthcare Shares

The Cochlear share price hit a 52-week low last week, is it time to buy?

Is this an opportunity worth hearing about?

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Earnings Results

Cochlear share price sinks 10% on half-year result disappointment

Let's see why investors are hitting the sell button this morning.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

The CSL share price hit a 52-week low this week. Is it time to buy?

Is this beaten-up biotech a healthy opportunity?

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Sigma share price up 9% on first day of trading post-merger with Chemist Warehouse

It's a post-merger party for Sigma Healthcare shareholders today.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock.

Read more »

Stethoscope with a piggy bank in the middle.
Healthcare Shares

With revenue up 9%, why does the NIB share price keep falling?

Will the ailing share price make a full recovery?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

Read more »

Woman with headphones on relaxing and looking at her phone happily.
Healthcare Shares

Everything you need to know about the latest CSL dividend

CSL's latest dividend should be turning investors' heads...

Read more »